How to buy ProPhase Labs stock (PRPH)

ProPhase Labs is a diagnostics & research business based in the US. ProPhase Labs shares (PRPH) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.63 – an increase of 2.56% over the previous week. ProPhase Labs employs 113 staff and has a trailing 12-month revenue of around $18 million.

Our top picks for where to buy ProPhase Labs stock

Buy ProPhase Labs stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

ProPhase Labs stock price (NASDAQ: PRPH)

Use our graph to track the performance of PRPH stocks over time.

ProPhase Labs shares at a glance

• Key figures

Information last updated 2024-12-25.

Latest market close	$0.63
52-week range	$0.61 - $7.48
50-day moving average more info button	$1.27
200-day moving average more info button	$3.35
Wall St. target price	$18.50
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-1.53

Is it a good time to buy ProPhase Labs stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

ProPhase Labs price performance over time

Historical closes compared with the close of $0.6261 from 2024-12-26

1 week (2024-12-20)	2.56%
1 month (2024-11-27)	-18.69%
3 months (2024-09-27)	-73.91%
6 months (2024-06-27)	-85.34%

1 year (2023-12-27)	-86.48%
2 years (2022-12-27)	-93.41%
3 years (2021-12-27)	6.8871
5 years (2019-12-27)	1.7898

ProPhase Labs financials

Revenue TTM	$18 million
Gross profit TTM	$70.7 million
Return on assets TTM	-22.98%
Return on equity TTM	-50.92%
Profit margin	-146.39%
Book value	$2.74
Market Capitalization more info button	$15 million

TTM: trailing 12 months

ProPhase Labs share dividends

We're not expecting ProPhase Labs to pay a dividend over the next 12 months.

Have ProPhase Labs's shares ever split?

ProPhase Labs's shares were split on a 2:1 basis on 22 January 1997 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your ProPhase Labs shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for ProPhase Labs shares which in turn could have impacted ProPhase Labs's share price.

ProPhase Labs share price volatility

Over the last 12 months, ProPhase Labs's shares have ranged in value from as little as $0.6105 up to $7.48. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ProPhase Labs's is -0.095. This would suggest that ProPhase Labs's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, ProPhase Labs has bucked the trend.

ProPhase Labs overview

ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular and DNA testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation.

Frequently asked questions

What percentage of ProPhase Labs is owned by insiders or institutions?
Currently 14.337% of ProPhase Labs shares are held by insiders and 7.635% by institutions. How many people work for ProPhase Labs?
Latest data suggests 113 work at ProPhase Labs. When does the fiscal year end for ProPhase Labs?
ProPhase Labs's fiscal year ends in December. Where is ProPhase Labs based?
ProPhase Labs's address is: 711 Stewart Avenue, Garden City, NY, United States, 11530 What is ProPhase Labs's ISIN number?
ProPhase Labs's international securities identification number is: US74345W1080 What is ProPhase Labs's CUSIP number?
ProPhase Labs's Committee on Uniform Securities Identification Procedures number is: 74838L304